Peptic Ulcer
📧 Sign up to get email alerts when something new happens for Peptic Ulcer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Ilaprazole 10 mg to prevent NSAID-associated peptic ulcers; currently recruitin…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers [Phase 3]
A Phase 3 study evaluating JP-1366 to prevent NSAIDs-induced peptic ulcers is currently recruiting.
-
FDA approval · 2023-09-14FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic formulation of chlordiazepoxide hydrochloride and clidinium bromide from Aurobindo Pharma Limited under an Original A…
-
FDA approval · 2023-07-21FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for a generic combination of chlordiazepoxide hydrochloride and clidinium bromide from Amneal, enabl…
-
FDA approval · 2023-04-28FDA Approved: OMEPRAZOLE — Original Application (Aurohealth LLC)
FDA approved Aurohealth LLC's original ANDA for omeprazole, enabling the marketing of a generic proton pump inhibitor in the United States. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing high-dose esomeprazole and amoxicillin dual therapy to bismuth-containing quadruple therapy for Helicobacter pylori-…
-
FDA label_change · 2020-11-27FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP to update the labeli…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer [NA]
A completed clinical trial evaluating whether a H2 receptor antagonist can prevent peptic ulcers related to thienopyridine use.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users [Phase 2]
Phase 2 trial assessing efficacy and safety of PMK-S005 to prevent recurrent peptic ulcers in low-dose aspirin users has completed.
-
CLINICAL_TRIALS withdrawal · 2015-04-08Clinical Trial Update: Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding [Phase 4]
A Phase 4 trial comparing esomeprazole and pantoprazole for preventing peptic ulcer rebleeding has been withdrawn.
-
FDA approval · 2013-04-05FDA Approved: BASIC CARE LANSOPRAZOLE — Supplemental Application (Amazon.com Services LLC)
FDA approved a supplemental application for BASIC CARE LANSOPRAZOLE (lansoprazole) from Amazon.com Services LLC, a generic lansoprazole prod…
-
FDA approval · 2012-02-29FDA Approved: ACID REDUCER — Original Application (WinCo Foods, LLC)
FDA approved an original application for a generic ranitidine hydrochloride product called ACID REDUCER by WinCo Foods, LLC.
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers [Phase 1]
A Phase 1 study comparing Allergan's AGN 201904 to esomeprazole for preventing aspirin-related damage to the stomach and upper intestine in …
-
FDA approval · 2010-10-27FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine submitted by Pharmaceutical Associates, Inc. The approval updates the product's e…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract
This clinical trial update evaluates the usefulness of fecal calprotectin as a diagnostic biomarker for upper gastrointestinal tract disorde…
-
CLINICAL_TRIALS trial_result · 2007-06-06Clinical Trial Update: Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy [Phase 4]
A Phase 4 trial evaluating high-dose intravenous proton pump inhibitor before endoscopy in peptic ulcer-related upper gastrointestinal bleed…